STATIN-FIBRATE REPORT: Focus on Safety

In IDNT, 1715 patients with HTN, type 2 DM and nephropathy were randomized to irbesartan 300mg once daily, amlodipine 10mg once daily, or placebo for a mean follow-up of 2.6 years.44 In RENAAL, 1513 patients with type 2 DM and nephropathy (with over 90% % on antihypertensive medications) were randomized to losartan 50-100mg once daily (71% ... ................
................